Atossa Therapeutics Inc.

07/22/2024 | Press release | Distributed by Public on 07/22/2024 07:35

Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z) Endoxifen as a Neoadjuvant Treatment for ER+[...]